Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Mov Disord. 2016 May 23;31(7):989–994. doi: 10.1002/mds.26666

Table 1.

Characteristics of DLB participants at time of imaging

n= 167
Males (%) 134 (80)
ε4 carriers (%) 79 (49)
Cognitive impairment onset age, years 68 (63, 74)
MRI age, years 72 (67, 76)
Education 14 (12, 16)
DRS 125 (112, 133)
MMSE 24 (21, 27)
CDR sum of boxes 3.0 (2.0, 5.0)
UPDRS 8 (4, 13)
Time to death from cognitive impairment onset, years 7.38 (5.72, 10.20)
Time to death/censor from MRI, years 4.39 (2.13, 6.31)
Time to MRI from cognitive impairment onset, years 3.16 (2.04, 4.60)
Events (%) 120 (72)
Autopsies (%) 54 (32)
MCI (%) 37 (22)
Field strength 1.5T (%) 103 (62)
AChEI treatment 163 (98)

Median (interquartile range) reported for the continuous variables and counts (%) for the categorical variables. AChEI = acetylcholinesterase inhibitor.